Immunoturbidimetric Measurement of Transferrin by Dilena, B. A. & Peake, M. J.
j Dilena and Peake: Immunoturbidimetric raeasurement of tratisferrin 735
l
! J. Clin. Chem. Clin. Biochem.
Vol. 24, 1986, pp. 735-740
© 1986 Walter de Gruyter & Co.
Berlin · New York
Immunoturbidimetric Measurement of Transferrin
By B. A. Dilena and M. J. Peake
Department of Biochemistry and Chemical Pathology, Flinders Medical Centre, Bedford Park, South Australia
5042, Australia
. (Received January 13/May 15, 1986)
Summary: This paper describes the development of an automated immunoturbidimetric assay for transferrin
on a centrifugal analyser. Regression analysis of transferrin values measured immunoturbidimetrically demon-
strates good agreement with data obtained by radial immunodiffusion (y = 0.997 + 0.024 g/l, r = 0.980,
n = 50). The assay has a detection limit of 1.0 g/l and working ränge of approximately 1.0 to 6.0 g/l of
transferrin. Day-to-day coefficient of Variation is less than 3.5%. Immunoturbidimetric transferrin (g/l) and
total iron binding capacity values ( / ) were compared using an established total iron binding capacity
method (y = 0.050 — 0.030 g/l, r = 0.967, n = 50). Minimal interference was found for lipaemic, haemo-
lysed or icteric samples. Transferrin reference values with a mean of 3.05 g/l and 95% limits from 2.45 to
3.65 g/l were derived using serum froin 300 apparently healthy subjects (150 males, 150 females). We conclude
that the proposed transferrin method is more reliable and easier to perform than presently available total
iron binding capacity methods.
Immunturbidimetrische Bestimmung von Transferrin
Zusammenfassung: Wir beschreiben eine immunturbidimetrische Methode zur Bestimmung von Transferrin
an einem Zentrifügalanalysator. Die Regressionsanalyse der immunturbidimetrisch gemessenen Transferrin-
werte zeigt gute Übereinstimmung mit Ergebnissen der radialen Immundiffusion (y = 0,997 + 0,024 g/l,
r = 0,980, n = 50). Die Methode hat eine Nachweisgrenze von 1,0 g/l und einen Arbeitsbereich von l —6 g/l
Transferrin. Der Variationskoeffizient von Tag zu Tag ist kleiner als 3,5%. Immunturbidimetrisch bestimmtes
Transferrin (g/l) und gesamte Eisenbindungskapazität ( >1/1) wurden verglichen: y = 0,050 — 0,030 g/l,
r = 0,967, n = 50). Für lipamische, hämolytische oder ikterische Proben wurden minimalen Störungen
beobachtet. Im Serum von 300 offensichtlich gesunden Personen (150 Männer, 150 Frauen) wurden Referenz-
werte ermittelt: = 3,05 g/l; 95%-Bereich 2,45 — 3,65 g/l. Wir schließen, daß die vorgestellte Transferrinme-
thode zuverlässiger und leichter durchführbar ist als gegenwärtig vorhandene Methoden zur Bestimmung der
gesamten Eisenbindungskapazität.
Introduction chemical (3) and radiometric methods (4) for measur-
t. t , , - - , , ing total iron binding capacity has been disappointingIn recent years, very rehabte methods have been de-
 in ^  ^  ^  han(Js of ouf most experienced staff.
veloped for the measuremeiit of serum iron. The
measurement of total iron binding capacity however, Transferrin, the main serum iron binding protein (5),
still presents many problems to the clinical biochem- has been measured by some laboratories äs an al-
ist, and this is evidenced by poor precision and accu- ternative to total iron binding capacity in order to
racy in quality assurance programmes (l, 2). In our eliminate technical problems associated with the satu-
own laboratory, long-term performance of both ration of transferrin and removal of excess iron (6).
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We investigated the use of a centrifugal analyser for
measuring transferrin immunoturbidimetrically using
a recently released Software Option for processing
non-linear Standard curves. We report our attempts
to establish a more reliable and less time-consuming
substitute for total iron binding capacity assays.
Materials and Methods
Initial procedure
Transferrin was measured on Cobas Bio (Hoffmann-La R che,
Basel, Switzerland) using an immunological transferrin proce-
dure s recommended (Boehringer Mannheim GmbH Cat. No.
661040 — Tab. 1). Patient specimens, quality control materials,
and a set of 5 transferrin Standards (Boehringer, Cat. No.
475785) were carefully diluted l in 11 prior to analysis by
mixing 100 μΐ of sample with 1ml of 9 g/l NaCl using a
Brand Diiuette model DL 2/0.1 (Rudolf Brand, Wertheim, W.
Germany). Diluted Standards were reused for convenience and
economy and were stable for 2 weeks at 4 °C. Fibrin deposition
in patient samples was avoided by using serum instead of
plasma.
Modified ^procedure
Four modifications were made to improve precision.
1. Anti-transferrin was added s a "start" reagent to samples
pre-incubated with buffer in Cobas Bio instead of the recom-
mended simultaneous addition of sample and anti-transfer-
rin. The anti-transferrin was dissolved in 2 ml of buffer rather
than 10ml for use s a "start reagent" and one fifth the
volume was used for each assay (tab. 1).
2. Pre-dilution was changed from l in 11 to l in 21 (100 μΐ of
sample + 2.0 ml of 9 g/l NaCl) to provide a bigger reserve
of diluted Standards.
3. Cobas Bio sample volume was increased from 5 μΐ to 15 μΐ
to compensate for the change in sample pre-dilution and to
generate more reliable absorbance changes for low concen-
trations of transferrin.
4. An additional Standard with a transferrin concentration
approximating the mid-point of the reference r nge was
prepared from a 50: 50 mixture of pre-diluted Boehringer
Standards 2 and 4. The Cobas Bio log-logit Standard curve
was then defined using the maximum number of 6 Standards.
Comparative methods
A radial immunodiffusion method (Behring NOR Partigen
Plate OUCK 02/03) was used s a comparative method for
transferrin. Fifty patient samples were analysed by both
methods. A total iron binding capacity method (7) involving
the measurement of the iron concentration (R che Product No.
0710598) of iron-saturated serum from which excess iron had
been removed by magnesium carbonate (R che Product N o.
0710075) was used for comparirig total iron binding capacity
and immunoturbidimetric transfefrin concentrations on an ad-
ditional 50 serum samples. Total iron binding capacity measure-^
ments were also performed using Cobas Bio.
Precision studies
Within run and day-to-day precision was monitored using
Omega l and 2 quality control materials (Hyland Diagnostics,
Illinois, U. S. A.). These were diluted with each batch of serum
samples prior to analysis on Cobas Bio.
Tab. 1. Cobas Bio Centrifugal Analyser settings for the assay
of transferrin
Parameter
1. Units
2. Calculation factor
3. Standard 1 conc · »
Standard 2 conc
Standard 3 conc
Standard 4 conc
Standard 5 conc
Standard 6 conc
6. Limit
7. Temperature, °C
8. Type of analysis
9. Wavelength, nm
10. Sample volume, μΐ
11. Diluent volume, μΐ
12. Reagent volume, μΐ
13. Incubation time, s
14. Start reagent volume, μΐ
15. First reading, s
16. Time interval, s
17. Np. of readings
18. Blanking mode
19. Printout mode
a) Sample pre-diluted 1 in 1 1
b) Sample pre-diluted 1 in 21
Initial
settings
g/l
1000
1.13
1.97
3.36
4.78
6.08
0.00
0
25
7.5
340
5a)
60
250C)
0
0
5
240
2
1
1
Modified
settings
g/l
1000
1.13
1.97
2.67
3.36
4.78
6.08
0
25
7.6
340
15b)
60
200d)
60
50«)
5
10
25
1
1
c) Buffered anti-transferrin (anti-serum dissolved in 10 ml of
buffer)
d) Buffer without anti-transferrin
e) Buffered anti-serum (anti-serum dissolved in 2 ml of buffer).
Reference values
Fifty blood specimens were collected from both males and
females in age groups 20 -> 39, 40 -» 59, and pver 60 years. In
total, 300 specimens were collected from apparently healthy
individuals with haemoglobin > 1.86 mmol/1 (males) and 1.78
mmol/I (females). Transferrin reference values with 95% limits
were established using the parametric Hoffman procedure (8).
A non-parametric classification by age and sex was also derived
(9).
Results and Discussion
Method development
Initial attempts to analyse transferrin on Cobas Bio
s recommended by Boehringer were unsuccessful.
Within-run imprecision was often greater than 5%
and it was not unusual to obtain individual results
more than 20% lower than expected; Falsely low
results were invariably accompanied by falsely high
initial absorbance readings 5 seconds after mixing
sample with buffered antiserum. It was impossible to
completely eliminate this problem, even when initial
absorbance meas rements were delayed s long s 15
seconds, and by this time the reaction had progressed
significantly. The mixing cycle was checked by a
R che engineer and found to be performing to specifi-
cations, and the same problem was reproduced on
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Tab. 2. Precision studies for the immunoturbidimetric transfer-
rin assay.
Sample
Within-run*)
Omega I
Omega II
Day-to-day*)
Omega I
Omega II
Mean
(g/D
2.134, 2.146
2.981, 2.975
2.129
2.896
SD
(g/l)
0.045, 0.039
0.012, 0.015
0.064
0.100
CV
(%)
2.10,
0.41,
3.01
3.45
1.81
0.52
a) Within-run precision measured in consecutive runs. 28 ali-
quots of each QC material were analysed per run.
b) Day-to-day precision over the flrst 5 months of routine use.
81 analyses of each QC material were performed.
another Instrument. We therefore decided to quanti-
tate transferrin using a mode of analysis that enabled
anti-transferrin to be added s a "start" reagent to
samples which had been pre-mixed with buffer during
an incubation phase. It was then possible to make a
reliable sample blank absorbance measurement s
well s monitor the complete reaction absorbance
change. Precision improved substantially to that of
conventional spectrophotometric assays and within-
rotor CV was often less than 1% (tab. 2). Other
modifications were then introduced to further im-
prove the assay.
When the amount of sample added to the antiserum
was increased by approximately 50%, better precision
was obtained for both patient samples and Standard
curves. More consistent Standard curves were also
generated from run to run, and absorbance change
doubled for low concentrations of transferrin where
good precision is most difficult to obtain (fig. 1). The
reliability of the calibration procedure was further
improved by using 6 Standards instead of 5. With
these modifications, fewer iterations were needed to
derive a log-logit Standard curve, and individual Stan-
dards showed very little deviation about the line of
best fit. It was found that low concentration Stan-
dards react with anti-transferrin much more slowly
than the high concentration Standards, and only the
latter near end-point after a four minute reaction
period. A comparison between Standard curves ob-
tained at four minutes and ten minutes is shown in
figure 1. The two lowest Standards reach only 50%
and 75% of the ten minute absorbance after four
minutes, in comparison with 85% by the higher Stan-
dards. We elected to use a four minute reaction period
to reduce analysis time, although longer times or less
sample pre-dilution may be more appropriate when
analysing mainly low concentration samples.
Immunoturbidimetric and radial immuno-
diffusion transferrin comparisons
The accuracy of the immunoturbidimetric transferrin
assay was assessed by assaying 50 patient sera in
duplicate by this method and also by a radial immu-
nodiffusion method. Results are shown in figure 2.
0.5
0.3
0.2
0.1
2.0 40
Transferrin [g/l]
6.0
Fig. 1. Transferrin Standard curves:
A. Sample vplume = 15 μΙ, pre-dilution = l in 21,
reaction time = 10 min
B. Samjple volume = 15 μΐ, pre-dilution == l in 21,
reaction time — 4 min
C. Sample volume = 5 μΐ, pre-dilution = l in 11,
reaction time = 4 min
1.0 2.0 3,0 4.0 5.0
Transferrin (radial immunodiffusion)[g/U
Fig. 2. Comparison of patient specimens analysed for transfer-
rin using an immunoturbidimetric method on Cobas
Bio and a radial immunodiffusion method.
yintercept = 0.024
slope = 0.997
r = 0.980
n =50
sy.x = 0.169
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The following relationship between methods was es-
tablished (concentrations in g/l):
Immunoturbidimetric transferrin = (0.997 χ radial
immunodiffusion) + 0.024, r = 0.980, sy.x = 0.169.
Good agreement was found between individual re-
sults and no significant differences were found for
visibly lipaemic, icteric or haemolysed samples.
Interference studies
Interference from haemoglobin and bilirabin was as-
sessed by adding 100 μΐ of concentrated Solutions of
haemolysate and bilirubin (Sigma 98 + %, catalogue
number B 4126) to 10ml aliquots of a serum pool
with an undetectable concentration of haemoglobin
and a low concentration of bilirubin (< 10 μιηοΐ/ΐ).
The serum pool was then adjusted with saline in the
same ratio. Each sample was analysed in quadrupli-
cate in ttie same run. No interference was detected
from haemoglobin or bilirubin up to the highest
concentrations of each substance tested, namely bili-
rubin, 600 μπιοΐ/ΐ and haemoglobin, 43 μιηοΐ/ΐ (ap-
pearance of gross haemolysis). Even at these concen-
trations of haemoglobin and bilirubin, the transferrin
concentration was the same s the pool (3.26 ±
0,01 g/l, 95% confidence limits), thus demonstrating
absence of interference.
Interference from lipaemia was assessed by measuring
the transferrin concentration of a grossly lipaemic
serum pool before and after ultracentrifugation to
remove triglyceride rieh particles in a Beckman Air-
fuge (Beckman Instruments Incorporated, Palo Alto,
CA 94304). The transferrin concentrations before and
after ultracentrifugation were 3.00 ± 0.01 g/l and
3.08 ± 0.01 g/l respectively. The slightly lower con-
centration in the lipaemic sample is consistent with
a dilution effect of lipid particles, s the sodium
and Chloride concentrations were approximately 2%
lower for this sample.
Immunoturbidimetric t ransferr in and total
iron binding capacity comparisons
It has been suggested that transferrin can be con-
verted to total iron binding capacity using the
relationship total iron binding capacity (μπιοΐ/l) =
transferrin (g/l) χ 22.75, based on a transferrin mol-
ecular weight of 88000 and a transferrin binding
capacity of 2 mol of iron per mol of transferrin (10).
We checked this experimentally using a total iron
binding capacity method in which excess iron is re-
5.0
4.0
o
o
l 3.0
2.0
c
"£ 10
Sσ
0 ' 2 0 O 60 80 100
Total iron binding capacity (MgC03) [μπηοΐ/ΐ]
Fig. 3. Comparison of patient specimens analysed for transfer-
rin using an immunoturbidimetric method and total
iron binding capacity s described in the "Materials and
Methods".
y intercept = —0.03
slope = 0.050
r = 0.967
n = 5 0
syx = 0.183
moved with magnesium carbonate (7). The following
relationship between immunoturbidimetric transfer-
rin (g/l) and total iron binding capacity (μπιοΐ/l) was
derived by assaying 50 additional patient sera:
Immunoturbidimetric transferrin = (0.050 χ total
iron binding capacity) —0.030, r = 0,967, sy.x =
0.183. Results are shown in figure 3.
Using the same molecular weight of 88 000 for trans-
ferrin, this implies an approxiinate transferrin binding
capacity of 1.8 mol of iron per mol of transferrin
under the conditions used to measure total iron bind-
ing capacity in this assay. Transferrin can be con-
verted to an approximate total iron binding capacity
(μιηοΐ/ΐ) by multiplying transferrin (g/l) χ 20.2. The
reliability of this conversion will depend on the
methods used and the contribution to total iron bind-
ing capacity of proteins other than transferrin (11).
Linearity
Linearity was assessed by making serial dilutions of
a serum pool with a high transferrin concentration.
Linearity was acceptable over the r nge of Standards
used to construct the non-linear calibration curve (l .0
-+, 6.0 g/l). Results above and below these limits are
identified s outside the rangfe of the assay.
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Detection limit
Detection limit was measured using the protocol rec-
ommended by the International Föderation of Clini-
cal Chemistry for assessment of analytical methods
for routine use (12). At transferrin concentrations
near zero, the Standard deviation was 0.36 and 0.40
g/l in two independent runs, giving a detection limit
of 0.99 g/l. Thus below l .0 g/l, absorbance changes
are too small for reliable transferrin measurements,
and less dilute samples or larger sample volumes
should be used.
Reference ränge
Transferrin reference values with a mean of 3.05 g/l
and 95% limits from 2.45 to 3.65 g/l were derived
using serum from 300 apparently healthy subjects
(150 males, 150 females). Data was processed by the
method of Hoffman (8). A normal probability plot
indicated a very small group of transferrin values
from females in the 20 to 39 year age group and
males over 60 years that did not belong to the main
distribution of results (possibly due to latent iron
deficiency or oestrogens).
An equivalent reference ränge was found for males
and females (2.45 — 3.65 g/l). A non-parametric sum-
mary (9) of all results according to age and sex is
provided in table 3. This data should be interpreted
with allowance made for the number of subjects
(n = 50) in each group.
General comments
In routine use, the new assay is easy to perform,
and 19 samples can be anälysed in approximately 30
minutes. In many instances, analysis time for the
same number of total iron binding capacity measure-
ments ön an Auto-Analyzef (3) was more than half
a day due to Problems such äs drifting baselines,
changing sensitivity, Fe(OH)3 contamination of satu-
rants, and inefficient removal of excess iron by anion
exchange resins. The transferrin method is relatively
inexpensive, costing approximately US $ 0.21 or DM
0.48 per assay, and this could be further reduced by
laboratories prepared to experiment with alternative
antisera.
Tab. 3. Data distribution (non-parametric).
Subjects
Males
All
20-39 years
40 -59 years
>60 years
Females
All
20-39 years
40-59 years
^60 years
Males and Females
Number
150
50
50
50
150
50
50
50
300
Mean
(g/D
3.07
3.01
3.00
3.22
3.12
3.23
3.12
2.99
3.09
95% Limits(g/i)
2.47-3.60
2.40-3.49
2.47-3.42
2.70-4.09
2.52-3.82
2.54-4.25
2.58-3.81
2.50-3.61
2.50-3.81
Conclusions
In summary, we believe that the Cobas Bio centrifugal
analyser is a useful Instrument for the immunoturbi-
dimetric measurement of transferrin, provided ab-
sorbance measurements taken soon after the mixing
cycle are not used for calculations. Antigen excess is
not a problem in this assay (l 3). Initial problems may
be related to small air bubbles generated in the mixing
cycle in the buffered anti-transferrin reagent. We have
observed that surfactant can cause falsely high absor-
bances immediately after the mixing cycle in conven-
tional photometric assays (e. g. magnesium estima-
tions using calmagite).
For routine diagnostic investigations, we now mea-
sure transferrin in place of total iron binding capacity.
Although theoretical and experimental relationships
can be used to convert one to the other, such conver-
sions should be interpreted carefully due to iron bind-
ing proteins other than transferrin (5,11). Most inves-
tigations concerning transferrin have been related to
haematopoiesis, nutrition, infection and cell prolifer-
ation and it has recently been suggested that low
levels of transferrin may prejudice the success of bone
marrow transplantation and major surgery (14, 15).
We believe that the present assay is ideal for such
investigations.
References
1.. Penberthy, L. A. (1985) Clin. Biochem. Revs. 5, 145-152.
2. Itano, M. (1976) Am. J. Clin. PathoL 66, 244-247.
3. Giovanniello, T. J., Di Benedetto, G., Palmer, D. W. &
Peters Jr., T. (1968) In: Automation in Analytical Chem-
istry, Tecihnicon symposia 1967 Volume l (Boehm, P.S.,
ed.). Mediad Incorporated, New York, pp. 185-188.
4. Fudge, A. N. & Fräser, C. G. (1978) Clin. Chem. 24,
374-376.
5. Dixon, K. (1973) Ann. Clin. Biochem. W, 127-131.
6. Williams, H. L. & Conrad, M. E. (1972) Clin. Chim. Acta.
37, 131-140.
7 Rarasay, W. N. M. (1957) Clin. Chim. Acta 2, 221-226.
J. Clin. Chem. Clin. Biochem. / Vol. 24,1986 / No. 10
740 Dilena and Peake: Immunoturbidimetric measurement öf traösferrin
8. HofTman, R. G. (1963) J. Amer. Med. Ass. 185, 864-873. 13. Spencer, K. & Price, C. P. (1980) In: Centrifugal Analysers
9. Solbert, H. E. (1983) J. Clin. Chem. Clin. Biochem. 21, in Clinical Chemistry, (Price, C. P. & Spencer, K„ eds.)
749—760. Praeger Scientific, Eastbourne, pp. 457--463.
10. Boehringer Mannheim GmbH Diagnostic (1982) Insert 14. Hunter, R. L., Bennett, B., Garrison, C., Wmton, E. F. &
supplied with transferrin method Cat. No. 661040. Vogler, W. R. (1984) Am. J. Clin. Pathöl. 81, 581-585.
11. Van der Heul, C., Van Eijk, H. G., Wiltink, W. F. & Leijnse, 15. Hunter, R, L., Bennett, B., Töwhs, M. & Voglers W. R.
B. (1972) Clin. Chim. Acta 38, 347-353. (1984) Am. J. Clin. Pathöl. 81, 748-753.
12. Büttner, J., Borth, R., Boutwell, J.H., Bfoughton, P. M.
G. & Bowyer, R. C. (1979) Clin. Chim. Acta. 98, ' r
145F-162F; J. Clin. Chem. Clin. Biochem. 18, 78-88 B. A. Dilena and M. J. Peake
(1980). Department of Biochemistry
and Chemical Pathology
Flinders Medical Centre
Bedford Park
South Australia 5042
Australia
J. CHn. Chem. Clin. Biochem. / Vol. 24,1986 / No. 10
